{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:30:29Z","timestamp":1791721829759,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Similarly to cortisol-secreting adrenal tumors, also non-functioning adrenal tumors (NFAT) may be associated with an increased cardiovascular risk. We assessed in NFAT patients: (i) the association between hypertension (HT), diabetes mellitus (DM), obesity (OB), dyslipidemia (DL) and cardiovascular events (CVE) and cortisol secretion; (ii) the cut-off of the cortisol secretion parameters for identifying NFAT patients with a worse cardiometabolic profile.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>In 615 NFAT patients (with cortisol levels after 1\u00a0mg overnight dexamethasone suppression test, F-1mgDST\u2009&lt;\u20091.8\u00a0\u00b5g\/dL [50\u00a0nmol\/L]) F-1mgDST and adrenocorticotroph hormone (ACTH) levels and data on HT, DM, OB, DL and CVEs prevalence were retrospectively collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HT, DM and HT <jats:italic>plus<\/jats:italic> DM were associated with F-1mgDST levels (area under the ROC curve: 0.588\u2009\u00b1\u20090.023, 0.610\u2009\u00b1\u20090.028, 0.611\u2009\u00b1\u20090.033, respectively, p\u2009&lt;\u20090.001 for all comparisons) but not with ACTH. The cut-off for identifying patients with either HT or DM or HT <jats:italic>plus<\/jats:italic> DM was set at\u2009\u2265\u20091.2\u00a0\u00b5g\/dL (33\u00a0nmol\/L). As compared with patients with F-1mgDST\u2009&lt;\u20091.2\u00a0\u00b5g\/dL (n\u2009=\u2009289), patients with F-1mgDST 1.2\u20131.79\u00a0\u00b5g\/dL (33\u201349.4\u00a0nmol\/L) (n\u2009=\u2009326) had lower ACTH levels (17.7\u2009\u00b1\u200911.9 vs 15.3\u2009\u00b1\u200910.1\u00a0pg\/mL, respectively, p\u2009=\u20090.008), older age (57.5\u2009\u00b1\u200912.3 vs 62.5\u2009\u00b1\u200910.9\u00a0years, respectively, p\u2009&lt;\u20090.001), and higher prevalence of HT (38.1% vs 52.5% respectively p\u2009&lt;\u20090.001), DM (13.1% vs 23.3%, respectively, p\u2009=\u20090.001), HT <jats:italic>plus<\/jats:italic> DM (8.3% vs 16.9%, respectively, p\u2009&lt;\u20090.002) and CVE (3.2% vs 7.3%, respectively, p\u2009=\u20090.028). F-1mgDST 1.2\u20131.79\u00a0\u00b5g\/dL was associated with either HT (odd ratio, OR, 1.55, 95% confidence interval, 95% CI 1.08\u20132.23, p\u2009=\u20090.018) or DM (OR 1.60, 95% CI 1.01\u20132.57, p\u2009=\u20090.045) after adjusting for age, gender, OB, DL, and DM (for HT) or HT (for DM), and with the presence of HT <jats:italic>plus<\/jats:italic> DM (OR 1.96, 95% CI 1.12\u20133.41, p\u2009=\u20090.018) after adjusting for age, gender, OB and DL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In NFAT patients, F-1mgDST 1.2\u20131.79\u00a0\u00b5g\/dL seems to be associated with a higher prevalence of HT and DM and a worse cardiometabolic profile, even if the poor accuracy of these associations suggests caution in interpreting these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01836-1","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:03:05Z","timestamp":1683046985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors"],"prefix":"10.1186","volume":"22","author":[{"given":"Vittoria","family":"Favero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Parazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Stefano","family":"Salcuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"1836_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175:G1-34.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1836_CR2","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A. Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab. 2021;106(11):3331\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1836_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011;96(5):1223\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"1836_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1210\/js.2019-00090","volume":"3","author":"J Park","year":"2019","unstructured":"Park J, de Luca A, Dutton H, Malcolm JC, Doyle MA. Cardiovascular outcomes in autonomous cortisol secretion and nonfunctioning adrenal adenoma: a systematic review. J Endocrine Soc. 2019;3:996\u20131008.","journal-title":"J Endocrine Soc."},{"issue":"7","key":"1836_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol. 2022;10(7):499\u2013508.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1836_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7326\/M20-7946","volume":"174","author":"A Kjellbom","year":"2021","unstructured":"Kjellbom A, Lindgren O, Puvaneswaralingam S, L\u00f6ndahl M, Olsen H. Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas. Ann Intern Med. 2021;174(8):1041\u20139.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1836_CR7","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"M Debono","year":"2014","unstructured":"Debono M, Bradburn M, Bull M, Harrison B, Ross RJ, Newell-Price J. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab. 2014;99(12):4462\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"1836_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"J Patrova","year":"2017","unstructured":"Patrova J, Kjellman M, Wahrenberg H, Falhammar H. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine. 2017;58:267\u201375.","journal-title":"Endocrine"},{"issue":"5","key":"1836_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G di Dalmazi","year":"2014","unstructured":"di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2(5):396\u2013405.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1836_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ando.2018.03.005","volume":"79","author":"V Morelli","year":"2018","unstructured":"Morelli V, Arosio M, Chiodini I. Cardiovascular mortality in patients with subclinical Cushing. Ann Endocrinol. 2018;79(3):149\u201352.","journal-title":"Ann Endocrinol"},{"issue":"2","key":"1836_CR11","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.beem.2021.101494","volume":"35","author":"C Aresta","year":"2021","unstructured":"Aresta C, Favero V, Morelli V, Giovanelli L, Parazzoli C, Falchetti A, et al. Cardiovascular complications of mild autonomous cortisol secretion. Best Pract Res Clin Endocrinol Metab. 2021;35(2):101494. https:\/\/doi.org\/10.1016\/j.beem.2021.101494.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"1836_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1210\/jc.2009-2387","volume":"95","author":"I Chiodini","year":"2010","unstructured":"Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab. 2010;95(6):2736\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1836_CR13","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/cpt.1551","volume":"106","author":"DA Delivanis","year":"2019","unstructured":"Delivanis DA, Athimulam S, Bancos I. Modern management of mild autonomous cortisol secretion. Clin Pharmacol Ther. 2019;106(6):1209\u201321.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1836_CR14","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1530\/EJE-16-0465","volume":"175","author":"I Bancos","year":"2016","unstructured":"Bancos I, Alahdab F, Crowley RK, Chortis V, Delivanis DA, Erickson D, et al. Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175(6):R283\u201395.","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"1836_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.898084","volume":"2","author":"V Morelli","year":"2022","unstructured":"Morelli V, Frigerio S, Aresta C, Passeri E, Pugliese F, Copetti M, et al. Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT. Front Endocrinol. 2022;2(13): 898084.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1836_CR16","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1210\/jc.2013-4064","volume":"99","author":"II Androulakis","year":"2014","unstructured":"Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, et al. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J Clin Endocrinol Metab. 2014;99(8):2754\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1836_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"165","author":"D Lopez","year":"2016","unstructured":"Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A. \u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study. Ann Intern Med. 2016;165(8):533\u201342.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1836_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","volume":"37","author":"MM Tuna","year":"2014","unstructured":"Tuna MM, Imga NN, Do\u01e7an BA, Yilmaz FM, Top\u00e7uo\u01e7lu C, Akbaba G, et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest. 2014;37(8):765\u20138.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1836_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12020-009-9160-8","volume":"35","author":"S Yener","year":"2009","unstructured":"Yener S, Genc S, Akinci B, Secil M, Demir T, Comlekci A, et al. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine. 2009;35(3):365\u201370.","journal-title":"Endocrine"},{"key":"1836_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, Delivanis DA, Khanna A, Prokop L, et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess a systematic review and meta-analysis. Anna Intern Med. 2019;171:107\u201316.","journal-title":"Anna Intern Med."},{"issue":"8","key":"1836_CR21","doi-asserted-by":"publisher","first-page":"bvaa079","DOI":"10.1210\/jendso\/bvaa079","volume":"4","author":"C Eller-Vainicher","year":"2020","unstructured":"Eller-Vainicher C, Morelli V, Aresta C, Salcuni AS, Falchetti A, Carnevale V, et al. Defining nonfunctioning adrenal adenomas on the basis of the occurrence of hypocortisolism after adrenalectomy. J Endocr Soc. 2020;4(8):bvaa079.","journal-title":"J Endocr Soc."},{"issue":"3","key":"1836_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2013-3527","volume":"99","author":"V Morelli","year":"2014","unstructured":"Morelli V, Reimondo G, Giordano R, della Casa S, Policola C, Palmieri S, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab. 2014;99(3):827\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1836_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/08037051.2014.868629","volume":"23","author":"G Mancia","year":"2014","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, et al. 2013 ESH\/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014;23(1):3\u201316.","journal-title":"Blood Press"},{"issue":"42","key":"1836_CR24","first-page":"S13","volume":"1","author":"Classification and diagnosis of diabetes","year":"2019","unstructured":"Classification and diagnosis of diabetes. Standards of medical care in diabetesd2019. Diabetes Care. 2019;1(42):S13-28.","journal-title":"Diabetes Care"},{"key":"1836_CR25","unstructured":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults the third report of the expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) constitutes the National [Internet]. Available from: https:\/\/jamanetwork.com\/"},{"key":"1836_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ntr\/ntp010","volume":"11","author":"CG Husten","year":"2009","unstructured":"Husten CG. How should we define light or intermittent smoking? Does it matter? Nicotine Tobacco Res. 2009;11:111\u201321.","journal-title":"Nicotine Tobacco Res."},{"issue":"6","key":"1836_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/cen.14745","volume":"97","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M. Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review. Clin Endocrinol (Oxf). 2022;97(6):693\u2013701.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1836_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40618-017-0788-6","volume":"41","author":"V Morelli","year":"2018","unstructured":"Morelli V, Minelli L, Eller-Vainicher C, Palmieri S, Cairoli E, Spada A, et al. Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism. J Endocrinol Invest. 2018;41(4):485\u201393.","journal-title":"J Endocrinol Invest"},{"key":"1836_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000443862","volume":"46","author":"I Chiodini","year":"2016","unstructured":"Chiodini I, Morelli V. Subclinical hypercortisolism: how to deal with it? Front Hormone Res. 2016;46:28\u201338.","journal-title":"Front Hormone Res."},{"key":"1836_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","volume":"64","author":"M Araujo-Castro","year":"2019","unstructured":"Araujo-Castro M, Sampedro N\u00fa\u00f1ez MA, Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine. 2019;64:1\u201313.","journal-title":"Endocrine"},{"issue":"4","key":"1836_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1210\/jc.2014-4177","volume":"100","author":"VV Zhukouskaya","year":"2015","unstructured":"Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Cairoli E, Ulivieri FM, Palmieri S, et al. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. J Clin Endocrinol Metab. 2015;100(4):1417\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1836_CR32","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1210\/jc.2019-00037","volume":"104","author":"I Chiodini","year":"2019","unstructured":"Chiodini I, Gaudio A, Eller-Vainicher C, Morelli V, Aresta C, Zhukouskaya VV, et al. Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women. J Clin Endocrinol Metab. 2019;104(10):4441\u20138.","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1186\/s12933-023-01863-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000}}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01836-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T12:03:47Z","timestamp":1685361827000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01836-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01836-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12933-023-01863-y","URL":"https:\/\/doi.org\/10.1186\/s12933-023-01863-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Istituto Auxologico Italiano and the Ethics Committee of Fondazione IRCCS C\u00e0 Granda-Ospedale Maggiore Policlinico, Milan, Italy. An informed consent has been obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}